OptiNose Competitors and Similar CompaniesClear all
OptiNose's competitors and similar companies include Veloxis Pharmaceuticals.
 Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. | ||
Founding Date | Founding Date 2000 | Founding Date 2002 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Morrisville, US HQ Oslo, NO Swindon, GB | Locations København, DK HQ Cary, US Cary, US |
Employees | Employees 2048% decrease | Employees 54 |
Financial | ||
Revenue (est.) | Revenue (est.) $78.2m (FY, 2024) | Revenue (est.) kr39.5m (FY, 2018) |
Cost of goods | Cost of goods $7.2m (FY, 2024) | Cost of goods kr7.9m (FY, 2018) |
Gross profit | Gross profit $71m (FY, 2024) | Gross profit kr31.6m (FY, 2018) |
Net income | Net income ($21.5m) (FY, 2024) | Net income (kr5.3m) (FY, 2018) |
Funding | ||
Total funding raised | Total funding raised $ 120.5m | Total funding raised $ 60m |
For sources of this data, please see the company profile
View Company Profiles
Veloxis Pharmaceuticals
HQ
København, DK
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View company